Bentoquatam is a topical medication intended to act as a shield against exposure to the irritating substance urushiol, found in plants such as poison ivy or poison oak. Bentoquatam contains... Bentoquatam contains bentonite, a clay, and is only effective as long as the film is visible on the skin.
- Mechanism
- Curator reviewed
The mechanism of action is unknown. It is thought topically applied bentoquatam acts as a physical barrier that interferes with the adsorption of antigens onto the skin and reduces absorption of antigens into the skin. It probably does not work by modifying the systemic allergic response.
- Primary indication
- Used to prevent or reduce the severity of allergic contact dermatitis due to urushiol, the allergenic resin of poison ivy, poison oak, and poison sumac.Curator reviewed
Resolves to
What you can answer from here — as of July 17, 2026
Which companies are running trials of Bentoquatam, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account